Skip to main content
Top

Current Breast Cancer Reports

Issue 2/2022

Content (3 Articles)

Magnetic Resonance Imaging Clinical Trials (JE Lang, Section Editor)

Personalized Screening and Prevention Based on Genetic Risk of Breast Cancer

Holly J. Pederson, Sandhya Pruthi

Fertility Fertility Issues and Breast Cancer (J Jeruss, Section Editor)

Anti-estrogen Therapy and Fertility Preservation in Premenopausal Breast Cancer Patients: a Review

Marcela Mazo Canola, Virginia G. Kaklamani

Fertility Fertility Issues and Breast Cancer (J Jeruss, Section Editor)

Reproductive Considerations for Patients with Early-Onset Breast Cancer

Versha Pleasant, Nicole Ulrich, Mark D. Pearlman, Molly B. Moravek

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine